Orchestra BioMed Holdings (OBIO) Debt Ratio (2021 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Debt Ratio for 5 consecutive years, with 0.14 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio fell 41.36% year-over-year to 0.14; the TTM figure through Mar 2026 stood at 0.14 (down 41.36% YoY), while the FY2025 annual figure was 0.12, down 33.79% from the prior year.
• Debt Ratio climbed to 0.14 in Q1 2026 per OBIO's latest filing, from 0.12 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.34 in Q2 2025 and bottomed at 0.07 in Q1 2023.
• Historically, Debt Ratio has averaged 0.15 across 5 years, with a median of 0.13 in 2025.
• Annual changes were most pronounced in 2025 — Debt Ratio tumbled 33.79% — and 2026, when it plunged 41.36%.
• Orchestra BioMed Holdings' Debt Ratio stood at 0.1 in 2022, then decreased by 16.92% to 0.08 in 2023, then surged by 127.44% to 0.19 in 2024, then plunged by 33.79% to 0.12 in 2025, then advanced by 14.63% to 0.14 in 2026.
• Business Quant data shows OBIO's Debt Ratio at 0.14 in Q1 2026, 0.12 in Q4 2025, and 0.14 in Q3 2025.